ADMA icon

ADMA Biologics

58 hedge funds and large institutions have $165M invested in ADMA Biologics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.

Holders
58
Holders Change
+3
Holders Change %
+5.45%
% of All Funds
1.33%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
23
Reduced
12
Closed
5
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
+$5K
Name Market Value Shares Shares
Change
Shares
Change %
PA
1
Perceptive Advisors
New York
$40.5M 6,521,102
CCM
2
Consonance Capital Management
New York
$28.2M 4,539,295 +290,061 +7%
BC
3
Broadfin Capital
New York
$27.7M 4,463,829 +1,214,000 +37%
AC
4
Aisling Capital
New York
$22.4M 3,608,171
BCM
5
Biomark Capital Management
Connecticut
$8.9M 1,433,304
Vanguard Group
6
Vanguard Group
Pennsylvania
$7.41M 1,192,641 +58,610 +5%
BlackRock
7
BlackRock
New York
$5.96M 959,772 -11,067 -1%
6CM
8
683 Capital Management
New York
$5M 805,000 -80,000 -9%
PVI
9
Pura Vida Investments
New York
$3.55M 571,317 +246,317 +76%
MWVC
10
Morgens Waterfall Vintiadis & Co
New York
$2.33M 375,000
State Street
11
State Street
Massachusetts
$1.78M 286,446 +9,441 +3%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.5M 242,112 +41,002 +20%
Northern Trust
13
Northern Trust
Illinois
$1.47M 236,009 +26,696 +13%
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$1.42M 228,999 +81,003 +55%
Renaissance Technologies
15
Renaissance Technologies
New York
$1.17M 188,300 +159,100 +545%
Deutsche Bank
16
Deutsche Bank
Germany
$689K 111,009 +74,711 +206%
KC
17
Kepos Capital
New York
$664K 107,000
AAP
18
Ardsley Advisory Partners
Connecticut
$621K 100,000 +20,000 +25%
Morgan Stanley
19
Morgan Stanley
New York
$418K 67,317 +19,137 +40%
Invesco
20
Invesco
Georgia
$381K 61,406 +15,133 +33%
DG
21
Delek Group
Israel
$361K 58,539 +58,539 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$340K 54,828
PCM
23
Prelude Capital Management
New York
$294K 47,400 -11,479 -19%
Charles Schwab
24
Charles Schwab
California
$272K 43,700 +8,300 +23%
Goldman Sachs
25
Goldman Sachs
New York
$204K 32,807 +32,807 New